Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDD0102 is a potent agonist of M1 Muscarinic receptor.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | CDD0102 is a potent agonist of M1 Muscarinic receptor. |
In vitro | CDD0102 displays much lower activity at M3 and M5 receptors. |
In vivo | CDD0102 (i.p.) crosses the blood-brain barrier (BBB) in a dose-dependent manner. In toxicological studies, the LD50 of CDD0102 is 190 mg/kg following i.p. injections and greater than 1,000 mg/kg following oral administration. CDD0102 (10 mg/kg) fully reverses memory deficits associated with IgG-192 saporin administration. Again, no side effects are observed at this dose. |
別名 | CDD0102A |
分子量 | 180.21 |
分子式 | C8H12N4O |
CAS No. | 146422-58-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDD0102 146422-58-4 Neuroscience AChR CDD 0102 CDD0102A CDD-0102 Inhibitor inhibitor inhibit